Transaction Report:
(Note: With the exception of the correction of typographical or spelling errors that could be a source of ambiguity, letters and reports are not edited. The original formatting of letters and referee reports may not be reflected in this compilation.) 1st Editorial Decision 22 September 2011
Thank you for the submission of your research manuscript to our editorial office. First of all, I would like to apologize for the unusual delay in getting back to you with a decision on your study. We have now received the full sets of reviews on your study.
As the reports are pasted below I would prefer not to repeat them here in detail, but to only summarize the main points raised by the referees. You will see that, while the referees agree on the potential interest of the findings, they also feel that additional work is needed to strengthen the conclusions put forward.
All referees point out some technical and formal issues that would need to be addressed. They also state that in some instances, additional discussions and/or further clarifications are needed. Referee 3, while acknowledging the technical quality of the findings, feels that additional insight into the function of CryB would be required. Upon further consultation with the other referees, reviewer 1 agrees with this assessment and some of his/her comments in the report also go in this direction. I would therefore kindly ask you to provide additional insight into the biological function of the enzyme or the relevance of cofactor binding. For example, cofactor bindings sites could be mutated and the effects on CryB activity could be assessed.
Overall, given the reviewers constructive comments and the potential interest of the study, I would like to give you the opportunity to revise your manuscript, with the understanding that the main concerns of the referees (as outlined above and in their reports) must be addressed. Acceptance of the manuscript will depend on a positive outcome of a second round of review and I should also remind you that it is EMBO reports policy to allow a single round of revision only and that therefore, acceptance or rejection of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript.
I look forward to seeing a revised form of your manuscript when it is ready.
Yours sincerely
Editor EMBO Reports REREREE REPORTS:
Referee #1:
Geisselbrecht and colleagues define a new subclass of cryptochromes, and present the first crystal structure of one of its members, the cryptochrome from Rhodobacter sphaeroides. Most importantly, the protein contains a new co-factor, 6,7-dimethyl-8-ribityl-lumazine, which has not been observed before in cryptochromes, and a [4Fe-4S] cluster in the catalytic domain, besides an FAD co-factor. Fig. 2A, B )."): It is not clear to how M406 is distinguishing. What is the functionality of this residue? What would happen to the structure if it were replaced by e.g. a Phe?
Referee #2:
The ms by Geissebrecht and colleagues described a study of the Rhodobacter sphaeroides cryptochrome, cryB. These authors provided the first structural analysis of this novel class of cryptochrome/photolyase superfamily. cryB is a member of the newly identified cryPro class of cryptochromes found in bacteria. The authors made two interesting findings of this unique class of cryptochromes: an antenna chromophore that is different from that of all previously studied cryptochromes, and a [4Fe-4S]2+ cluster that may act as a potential redox sensor but not found in most other cryptochromes. These novel new structural components of cryB appear to be consistent with the reported role of cryB in photosynthetic gene expression. The [4Fe-4S]2+ cluster may be presented in not only rhodebacteria but also cry3 of plants, suggesting a possible evolutionary connection between the cryPro and CRY-DASH class of cryptochromes. This finding is well suited to this journal.
Some minor comments:
1. The nomenclature of cryptochrome/photolyase superfamily has been widely used by most publications in this field. It seems unnecessary to introduce the new abbreviation of "c/p-family" to the field without much benefit other than save a few letters in describing this family of proteins (but with the disadvantage of creating more troubles for most readers).
2. Some sentences that contain apparent errors page 4: "For comparison, the other, major clusters of the p/cfamily are found in 635 proteo-and 53 cyanobacterial species."
Page 6: As replacement sufficient to support photoreduction a single water molecule (w1) is suitable placed within the FAD binding site to form H-bonds to the N5 nitrogen as well as to the backbone carbonyl of Y387.
Referee #3:
Geisselbrecht et al. present the structure of CryB from Rhodobacter sphaeroides and discuss their findings in detail. However, unfortunately, the paper contains only the structure and additional (though comprehensive) characterization. Although the findings are interesting and the work is carried out at the highest standards, I understand the focus of EMBO reports is on functional relevance. Indeed, as far as function is concerned, the article in its current form contains only conjecture. It may therefore be better to refer the current manuscript to another journal, where the focus is more on structures.
The authors use a variety of techniques to arrive at a comprehensive structural and chemical characterization of the protein, including protein crystallography and EPR. In doing so, they find an Fe4S4 cluster and a novel cofactor, which they identify as DLZ using, amongst other techniques, mass spectrometry.
There is, if one may be a bit difficult, the caveat that the MS analysis was done on recombinant protein from E.coli with pQEcryB (as the authors duly point out, unless I misunderstood this) and not on natural protein from Rhodobacter sphaeroides. However, given the apparent specificity it seems a safe assumption that in R. sphaeroides the same antenna cofactor will be used in the protein.
The crystallographic data and model statistics seem fine, apart from one thing: for the test set, 2000 reflections were used, which it would appear constitutes only 2.5% of the total. This is far less than what is usual. Do the authors have a reason for this? Also, how many test set reflections then remain for the higher resolution shells? Is this enough for a correct estimate of sigma-a? Figure 2A is very difficult to interpret, either a different orientation should be used, or part must be taken out, such as the loop leading to alpha helix 17. Also, the dashed line indicating the H-bond from Y387 to W1 is in front of this loop, though the H-bond seems to be behind it. Also, the legend to figure 2B speaks of "tryptophanes" which should be "tryptophans".
Some short comments the authors may find helpful: -p2, last sentence of the abstract: "... the latter is evolutionary related to ..." should be " ... the latter is evolutionarily related to ..." . -p2, introduction: " cryptochromes are manifold involved ..." should be rephrased. I don't immediately know how to repair this, but at least it should involve an adverb, rather than the adjective "manifold".
-p2, introduction, and further occurences: "e.g." is Latin, it should therefore be spelled using italics.
-p4. the determination of acid-labile sulfur (spelled "sulphur", though "sulfur" is the IUPAC spelling, as well as the spelling listed in my dictionary) is given as 4.0:1.0. However, 15.0 nmol/3.8 nmol equals ~3.947 which should then be given as 3.9:1.0. Or is this caused by rounding? -p5, line 6: "a five-pleaded beta-sheet" should be "a five-stranded beta-sheet".
-p5, fourth line from the bottom: "22.9 Å distant to the FAD" should be "at a distance of 22.9 Å from the FAD". 
GENERAL (EDITOR'S comments)
"They also state that in some instances, additional discussions and/or further clarifications are needed. Referee 3, while acknowledging the technical quality of the findings, feels that additional insight into the function of CryB would be required. Upon further consultation with the other referees, reviewer 1 agrees with this assessment and some of his/her comments in the report also go in this direction. I would therefore kindly ask you to provide additional insight into the biological function of the enzyme or the relevance of cofactor binding. For example, cofactor bindings sites could be mutated and the effects on CryB activity could be assessed."
As the biological function of RsCryB has been discovered and extensively discussed in Hendrischk et al. (2009), we felt that this manuscript has to deal on the structural/mechanistic aspects of this hitherto unknown family of cryptochromes. Accordingly, we followed the editor's advice of analyzing the pecularities of this member of the CryPro family in terms of its photoreduction pathway that is clearly different from all other known photolyases and cryptochromes using a combined approach of mutagenesis, spectroscopy and kinetics. Furthermore, we included some more functional findings about single-stranded DNA-binding (see below Ref. 1, page 5), where appropriate.
REFEREE 1:
"It would be very helpful to define in the first paragraph of the Results section the distinguishing features of the CryPro family (e.g. absence of reduction cascade Trps, presence of 4 Cys residues defining the [4Fe-4S] cluster, the presence of the roof domain extension). I think this is much more useful than mentioning how many species contribute to the various classes."
The referee is right. We changed the section (p. 4, first para) as suggested.
Page 4; Give explicit arguments why the [4Fe-4S] cluster behaves like a HiPIP cluster and not like a ferredoxin cluster
The referee may have misunderstood our point about similar, but not identical behaviour of our [4Fe-4S] cluster in regard to the HiPIP cluster. Accordingly, we added Figure SI4 to make clear that this cluster is indeed highly H-bonded to the protein backbone unlike the Fdx-type.
Page 5, line 6: five-pleaded &#x03B2;-sheet -> parallel, five-stranded &#x03B2;-sheet
The referee is right. We changed as suggested.
Page 5, please include references to the PDB entries mentioned
Page 5, why is the R365-D393 salt bridge so important that it merits mentioning?
The referee is right. Although we found it quite interesting that despite the many deviations this structural feature is maintained, we omitted it given the length restraints for the manuscript and its importance for the general readership.
Page 5, in Figure 5A indicate the location of the roof domain
The referee is right, when referring to Fig. 4C (no 5A in submitted manuscript). We added "Helices α19, α20 and α21 form the roof-like subdomain" in the legend of Fig 4 as suggested.
Page 5, last sentence of X-ray structure paragraph: make clear that this enzyme does not interact with DNA (or does it? This is not very clear from the manuscript). I think the authors carry out experiments to establish this beyond doubt.
The referee is only partly right. DNA-binding experiments have been actually already done with RsCryB in Hendrischk et al., 2009. There, it was shown that RsCryB is capable to bind singlestranded DNA with relatively high affinity, but double-stranded DNA by two orders of magnitude worse.
To clarify this, we ADDED "This modified groove allows non-specific DNA binding with high affinity as demonstrated before (Hendrischk et al, 2009 )." at the end of the X-ray para and modified the end of the para "FAD binding site" : "However, it is sterically constricted due to the contribution of the linker after helix α7 corroborating the finding that RsCryB binds single-stranded DNA ( The referee is right. We simply omitted "highly", because they are "absolutely" conserved.
Page 6, FAD binding site: is it possible that, upon substrate binding, the N5-binding water molecule is displaced by the E399 side chain? Can the authors exclude that such a conformational change may occur?
The referee is right that this may occur upon photoreduction or binding to appropriate substrates/ligands. Given the length limitation, we didn't discuss in speculative terms about what may happen. Ongoing experiments by us will hopefully give an insight into redox-dependent states of RsCryB.
Page 7, second paragraph ("The surroundings ... family ( Fig. 2A, B) ."): It is not clear to how M406 is distinguishing. What is the functionality of this residue? What would happen to the structure if it were replaced by e.g. a Phe?
We don't think that this residue is of utter importance. Instead, we focussed on aspects raised by referee 3. Accordingly, we omitted this residue from the presentation of the FAD environment.
REFEREE 2:
The nomenclature of cryptochrome/photolyase superfamily has been widely used by most publications in this field. It seems unnecessary to introduce the new abbreviation of "c/p-family" to the field without much benefit other than save a few letters in describing this family of proteins (but with the disadvantage of creating more troubles for most readers).
The referee is generally right and we thus refer to photolyase/cryptochrome family, although this requires more characters.
Some sentences that contain apparent errors … We checked the phrasing and the English by handling the manuscript to a native speaker and made hence several minor corrections throughout the text.
REFEREE 3:
The crystallographic data and model statistics seem fine, apart from one thing: for the test set, 2000 reflections were used, which it would appear constitutes only 2.5% of the total.
The referee is not right concerning the percentage of reflections used as R-free set. Generally, one obtains very stable R-free estimates with ~1000 reflections; it is the number not the percentage that is important. We took the double amount given the high overall number of reflections. However, the selection criteria are much more critical than the absolute number or percentage. We used shelled bins for the selection of the R-free test set, because of non-crystallographic symmetry with 3 molecules per asymmetric symmetry unit.
Some short comments the authors may find helpful:
Many, many thanks to the referee. We made the corrections and changes as indicated by ref. Thank you for your patience while we have reviewed your revised manuscript. As you will see from the reports below, the referees are now all positive about its publication in EMBO reports. I am therefore writing with an 'accept in principle' decision, which means that I will be happy to accept your manuscript for publication once a few minor issues/corrections have been addressed, as follows.
First, I noticed that there are 'supplementary results' in the supplementary section, which we cannot allow. I would therefore kindly ask you to incorporate these results into the main body of the text. Because of the length restrictions, it might be easiest if you combined the results and discussion section, which helps to avoid unnecessary redundancies. Please also note that you should not move the entire methods section from the main text into the supplementary section to make space for the incorporation of the supplementary results. I would also like to point out that all supplementary figures must be referred to in the main text, so please go through your manuscript and make sure that this is the case.
Second, I have taken the liberty to edit the abstract somewhat according to our style.
If all remaining corrections have been attended to, you will then receive an official decision letter from the journal accepting your manuscript for publication in the next available issue of EMBO reports. This letter will also include details of the further steps you need to take for the prompt inclusion of your manuscript in our next available issue.
Thank you for your contribution to EMBO reports.
Yours sincerely, Editor EMBO Reports REFEREE REPORTS:
The authors have addressed my comments and concerns to my satisfaction in the revised manuscript.
Geisselbrecht et al. describe an interesting new theme in the photolyase/cryptochrome family of enzymes. The work is of hogh quality and interest, and my earlier concerns have been dealt with. I therefore recommend publication in EMBO reports. Herewith, we like to submit our manuscript " CryB from Rhodobacter sphaeroides: A unique class of cryptochromes with novel cofactors " by Yann Geisselbrecht, Sebastian Frühwirth, Claudia Schröder, Antonio J. Pierik, Gabriele Klug, Lars-Oliver Essen for publication as Scientific Report in EMBO reports. This manuscript was already "accepted" by you, but you pointed that there had to be made a few formatting changes.
Pleased by your "accept in principle" decision, we followed your suggestions regarding the abstract and the supplementary results. We are grateful to use your rewritten abstract and included the supplementary results into the main text, as we merged the "Results" and "Discussion" sections. Instead, we close the manuscript now with a short Conclusion. The most important Material and Methods are included in the main text of the manuscript, still leaving a Supplementary Material&Methods section. Overall, the content & scope of the manuscript have not been touched by these minor changes.
Please contact me, if there remains anything to be clarified. I am very pleased to accept your manuscript for publication in the next available issue of EMBO reports.
Thank you for your contribution to EMBO reports and congratulations on a successful publication. Please consider us again in the future for your most exciting work.
Yours sincerely, Editor EMBO Reports
